Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / articles / ALXO - ALX Oncology to Host Investor Call and Webcast on October 3 2023 to Share Interim Phase 2 ASPEN-06 Clinical Trial Results of Evorpacept for the Treatment of Advanced HER2-Positive Gastric Cancer | Benzinga

ALXO - ALX Oncology to Host Investor Call and Webcast on October 3 2023 to Share Interim Phase 2 ASPEN-06 Clinical Trial Results of Evorpacept for the Treatment of Advanced HER2-Positive Gastric Cancer | Benzinga

ALX Oncology Holdings Inc.

  • SOUTH SAN FRANCISCO, Calif., Oct. 02, 2023 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., ("ALX Oncology" or the "Company") (NASDAQ:ALXO), an immuno-oncology company developing therapies that block the CD47 immune checkpoint pathway, today announced the hosting of an investor call and webcast on Tuesday, October 3rd at 8:00 AM EDT to share interim Phase 2 ASPEN-06 clinical trial results of evorpacept for the treatment of advanced HER2-positive gastric cancer.

    To access the ...

    Full story available on Benzinga.com

    •
    Stock Information
    Company Name: ALX Oncology Holdings Inc.
    Stock Symbol: ALXO
    Market: NASDAQ
    Website: alxoncology.com
    Menu
    ALXO ALXO Quote ALXO Short ALXO News ALXO Articles ALXO Message Board
    Get ALXO Alerts

    News, Short Squeeze, Breakout and More Instantly...